Items where Author is "NAWAWI, HAPIZAH BINTI MD"

NAWAWI, HAPIZAH BINTI MD (2009) Effects of Tocotrienol Rich Fraction (TRF) on the Molecular Pathogenesis of Atherosclerosis and Genes Regulating Inflammation & Oxidative Stress. In: UNSPECIFIED.

NAWAWI, HAPIZAH BINTI MD (2009) ARISTOTLE Study. In: UNSPECIFIED.

NAWAWI, HAPIZAH BINTI MD (2009) Heart Outcomes Prospective Epidemiology (HOPE)-3 Studies. In: UNSPECIFIED.

NAWAWI, HAPIZAH BINTI MD (2009) Tocotrienol is a more potent free radical scavenger than tocopherol in in vitro assay. In: UNSPECIFIED.

NAWAWI, HAPIZAH BINTI MD (2006) Tocotrienol has neutral effects on coronary risk markers in hypercholesterolaemic rabbits with established atherosclerosis. In: UNSPECIFIED.

NAWAWI, HAPIZAH BINTI MD (2006) Biomarkers of acute coronary syndrome � what should we measure? In: UNSPECIFIED.

NAWAWI, HAPIZAH BINTI MD (2006) Anti-inflammatory effects of tocotrienol is optimal at lower concentration than that as an antioxidant. In: UNSPECIFIED.

NAWAWI, HAPIZAH BINTI MD (2007) Short term tocotrienol intervention in rabbits induced established atherosclerosis on markers of oxidative stress, inflammation and atherosclerotic lesions. In: UNSPECIFIED.

NAWAWI, HAPIZAH BINTI MD (2007) Improvement in oxidative stress in patients with non-familial hypercholesterolaemia (NFH) treated with palm-oil derived vitamin E. In: UNSPECIFIED.

NAWAWI, HAPIZAH BINTI MD (2008) Effect of ambient temperature on analytical and clinical performance of a blood glucose monitoring system: Omnitest Sensor glucose meter. Annals of Clinical Biochemistry, 8 (1). ISSN 1511-9300

NAWAWI, HAPIZAH BINTI MD (2008) Elevated serum lipoprotein(a) levels in type 1 and type 2 diabetic patients among malaysian malays. Atherosclerosis Supplements, 4. ISSN 1553-345x

NAWAWI, HAPIZAH BINTI MD (2009) Improvement in oxidative stress in patients with non-familial hypercholesterolaemia (NFH) treated with palm-oil derived vitamin E. ISSN 1712-8056

NAWAWI, HAPIZAH BINTI MD (2003) Increment in serum osteocalcin levels with high dose statin treatment in patients with familial hypercholesterolemia.

NAWAWI, HAPIZAH BINTI MD (2008) Laboratory accreditation by ISO/IEC 15189 Standards.

NAWAWI, HAPIZAH BINTI MD (2008) PBL 7: Metabolic Syndrome. UNSPECIFIED.

NAWAWI, HAPIZAH BINTI MD (2005) Tocotrienol as an anti-inflammatory agent and anti-oxidant in atherosclerosis: Evidence from in vitro and in vivo studies.

NAWAWI, HAPIZAH BINTI MD (2007) UiTM kaji mikrograviti, inflamasi di angkasa lepas. UNSPECIFIED.

NAWAWI, HAPIZAH BINTI MD (2005) Newly diagnosed hypertensives are associated with biomarkers of atherosclerosis, thrombogenesis and inflammation. In: UNSPECIFIED.

NAWAWI, HAPIZAH BINTI MD (2006) The effects of tocotrienol on coronary risk markers in rabbits fed on high cholesterol diet. In: UNSPECIFIED.

NAWAWI, HAPIZAH BINTI MD (2008) The prevalence of suspected undiagnosed hypertension in rural communities and their cardiovascular risk factor profile. In: UNSPECIFIED.

NAWAWI, HAPIZAH BINTI MD (2008) Offsprings of hypertensive parents have similar risk factors as offsprings of non-hypertensive parents and do not have abnormalities in the endothelial function, inflammation and thrombogenesis markers. In: UNSPECIFIED.

NAWAWI, HAPIZAH BINTI MD (2005) Determination of coronary risk factors and risk factor equivalents in offspring�s hypertensive and ischaemic heart disease subjects. In: UNSPECIFIED.

NAWAWI, HAPIZAH BINTI MD (2005) Modification of hypertension and cardiovascular risk factors by lifestyle intervention in perimenopausal women. In: UNSPECIFIED.

NAWAWI, HAPIZAH BINTI MD (2005) Biomarkers in Acute Coronary Syndrome. In: UNSPECIFIED.

NAWAWI, HAPIZAH BINTI MD (2005) Moderate concentrations of tocotrienol reduces production of adhesion molecules by stimulated endothelial cells. In: UNSPECIFIED.

NAWAWI, HAPIZAH BINTI MD (2005) Increment in serum osteocalcin levels with high dose statin treatment in patients with familial hypercholesterolemia. In: UNSPECIFIED.

NAWAWI, HAPIZAH BINTI MD (2007) Tocotrienol as an anti-inflammatory agent and anti-oxidant in atherosclerosis: Evidence from in vitro and in vivo studies. In: UNSPECIFIED.

NAWAWI, HAPIZAH BINTI MD (2005) Effects of antioxidants on coronary risk markers in patients with hypercholesterolaemia in the high and moderate risk categories. In: UNSPECIFIED.

NAWAWI, HAPIZAH BINTI MD (2005) Laboratory accreditation by ISO/IEC 15189 Standards. In: UNSPECIFIED.

NAWAWI, HAPIZAH BINTI MD (2007) Molecular and cellular protective mechanisms of high density lipoprotein in hypercholesterolaemia. In: UNSPECIFIED.